Navigation Links
Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider

FORT LAUDERDALE, Fla., Aug. 25 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that their EDC tool, TrialMaster(TM), has been selected by Pleiad, Inc., a Cambridge, Massachusetts based Contract Research Organization (CRO) with European operations in the U.K., to provide eClinical services to its customers. Pleiad's investment will provide it with the products and services to manage two upcoming studies investigating the use of ophthalmic medical devices. This partnership is expected to generate more than $1 million to OmniComm over the next few years. Pleiad has worked with the TrialMaster EDC tool since April 2008 under OmniComm's CRO Preferred Program, and is now transitioning to a Technology Transfer model in order to provide greater value to its customers engaged in these important clinical trials.

"We are pleased to once again be collaborating with Pleiad, as the exposure generated from working closely on a continual basis with such a specialized, internationally renowned CRO will undoubtedly raise our profile within the international clinical community," commented Stephen Johnson, OmniComm's COO. "We expect that as we continue to work with well respected, high profile organizations such as Pleiad, we will continue to attract companies of an equally high caliber to our dramatically enhanced service offering. We feel that we can offer organizations engaged in clinical research a significant advantage over their peers with our highly specialized portfolio of eClinical solutions designed to greatly simplify the clinical process."

"TrialMaster has been an essential option for us to provide to our customers. Much is made about the importance of subject compliance in clinical research, but we find that study coordinator 'compliance' is also very critical. The TrialMaster EDC system is very intuitive, so the study coordinators with whom we work have little problem in getting their work completed within the allocated time," stated Stephen Brandao, Pleiad's Vice President of Business Development. "We find that OmniComm is an attentive partner, very much in tune with the needs of our business. Our team anticipates collaborating with them on future opportunities."

About Pleiad

Pleiad, Inc. is a clinical CRO (contract research organization) that specializes in expertly assisting medical device, combination, women's health, and ophthalmic product manufacturers meet the clinical, quality, safety and regulatory requirements of the product development process. Their work encompasses the progression from the conceptual and developmental stages to post-marketing trials, offering regulatory support, clinical trial management, and safety monitoring services.

About OmniComm

OmniComm Systems, Inc. ( provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey, the United Kingdom, and Russia as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

    Catherine Lemercier
    OmniComm Systems, Inc.
    954-473-1254 Extension 283

    Stephen Johnson at: + 1 954-377-1726

    Gary Nash
    CEOcast, Inc. for OmniComm

SOURCE OmniComm Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009
2. Inaugural Medical Device Connectivity Conference & Exhibition to Focus on Connecting Medical Devices to People, Workflow and Information Systems
3. CVS/pharmacy Enhancing Accessibility for the Visually Impaired To Its Web Site and Store Point of Sales Devices
4. Minnesotans to Keynote Materials for Medical Devices Conference
5. Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge
6. European Health Care Institutions Forced to Select Lower-Priced Interventional Cardiology Devices
7. Multiple Advantages to Boost Deployment of Wireless and Handheld Devices in Healthcare, States Frost & Sullivan
8. Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together
9. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
10. White Paper Explains Package Validation Requirements For Medical Devices & Combinatory Products
11. MPR Drug Database Available as a Free Download for Mobile Devices, Including BlackBerry and Palm
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to become ... invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the ... Wimbledon Athletics Facebook page to educate the public, parents and school ... About 2,000 people under the age of 25 die from sudden cardiac arrest ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: